CORDIS · 648927 · H2020
HoloVision Advanced holographic optical neural stimulation for vision restoration and basic research
Coordinator: TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY (IL)
When natural sensory input is disrupted, as in outer-retinal degenerative diseases, artificial stimulation of surviving nerve cells offers a potential strategy for bypassing compromised neural circuits and substituting sensory perception. Current neuro-stimulation interfaces that use electrical currents from micro-electrode arrays are already being clinically applied for retinal stimulation, but their performance is ultimately limited by current spread and the requirement for physical contact with an implanted device. Future minimally-invasive systems could use light patterns to photo-induce …
About Horizon 2020 (2014–2020)
Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.
EU contribution: €2.6M awarded to the consortium. The project runs over approximately 5 years from 2016-01-01 to 2020-12-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from IL
see all →- CloudCT — Climate CT- Cloud Tomography by Satellites for Better Climate Prediction810370 · H2020 · €13.9M
- LUCIA — Understanding Lung Cancer related risk factors and their Impact101096473 · HORIZON · €13.5M
- D2Smell — Digitising Smell: From Natural Statistics of Olfactory Perceptual Space to Digital Transmission of Odors101118977 · HORIZON · €11.8M
- SIIP — Speaker Identification Integrated Project607784 · FP7 · €10.5M
- SAVEME — A Modular Nanosystems Platform for Advanced Cancer Management: Nano-vehicles; Tumor Targeting and Penetration Agents; Molecular Imaging, Degradome based Therapy263307 · FP7 · €10.5M
- CATO — CATO - CBRN crisis management: Architecture, Technologies and Operational Procedures261693 · FP7 · €10.3M
Other H2020 projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint programme of the members of the EUROfusion consortium633053 · DE · €678.8M
- H2020 — COST at a turning point: A unique framework for pan-European ST cooperation as clear demonstration of European values681463 · BE · €178.2M
- HBP SGA3 — Human Brain Project Specific Grant Agreement 3945539 · BE · €150.0M
- COVID-19 VACCINES — PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19101018100 · NO · €100.0M
- UNITE4TB — ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS101007873 · NL · €92.5M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · ES · €89.8M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the ERC-COG funding scheme.
- What is the EU contribution?
- The European Commission contributes €2.6M toward a total project budget of €2.6M.
- Which EU programme funds it?
- The project is funded under Horizon 2020 (2014–2020), call ERC-2014-CoG.
- Who coordinates the project?
- The project is coordinated by TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY (IL).
- What is the project timeline?
- The project runs from 2016-01-01 to 2020-12-31 — approximately 5 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 648927.